NDC11 71104003501
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71104-0035-01 | 71104-0035 |
| 71104-0035-1 | 71104-0035 |
| 71104-035-01 | 71104-035 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALTUVIIIO | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL | Bioverativ Therapeutics Inc. | 01411972-df40-4ccf-88f0-d3220e5abda9 | 2026-02-23 | Warnings, Adverse reactions | 71104-035-01 71104003501 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.